ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep

This study has been completed.
Information provided by Penn State University

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
Official Title  Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Brief Summary

Cough is the most common reason for an acute care doctor's visit in the United States. Cough can affect sleep for both coughing children and their parents. The American Academy of Pediatrics does not endorse the use of dextromethorphan (DM), the most common over-the-counter (OTC) cough medication because of a lack of efficacy data and some potential for toxicity, particularly when taken in excess. In fact, DM has previously been shown to be no better than a placebo for cough in children. Therefore, alternative, therapeutic agents are needed. Honey anecdotally provides relief for symptoms due to upper respiratory tract infection (URI). This study seeks to use a survey to evaluate whether a single dose of honey and/or DM is better than no treatment at all for controlling nocturnal cough in children with URI and the effect of the treatments on sleep quality for coughing children and their parents. A single dose of honey or DM will be superior to no treatment for control of nocturnal cough due to upper URI as rated by both parents and children and will improve the sleep quality for those children and parents. Compared to DM, honey will be superior for controlling nocturnal cough due to upper URI (also based on child and parental report).

Detailed Description

Cough is one of the most common reasons for a doctor's visit in the United States and may be the most bothersome symptom for children with colds. It is particularly annoying at night because it can interrupt sleep for both coughing children and their parents. Dextromethorphan (DM), the most common over-the-counter (OTC) "cough medication," may not be as helpful for these symptoms as previously believed. Because of this, treatments are needed to better reduce the symptoms from a cold. Honey is a naturally occurring substance that may provide relief for cold symptoms. Children are being offered the opportunity to take part in this research because they have been diagnosed with a cold and have had difficulty sleeping due to their cough.

The purpose of this research is to use a survey to see if a single dose of honey or DM is better than no treatment at all for controlling nighttime cough in children, ages 2 to less than 18 years with a cold and if the medicine or honey helps the quality of sleep for the coughing children and their parents. DM has been approved by the Food and Drug Administration (FDA) and is available over the counter. The form of honey used in this study may also be purchased without a doctor's prescription.

About 125 male and female children from 2 to less than 18 years old will take part in this study at the Hershey Medical Center.

Study Phase Phase I
Study Type  Interventional
Study Design  Treatment, Randomized, Double-Blind, Active Control, Factorial Assignment, Efficacy Study
Primary Outcome Measure  Compared with no treatment, honey and DM will: improve the sleep quality for children with cough due to URI and improve the sleep quality for the parents of children with cough due to URI [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Secondary Outcome Measure 
Condition  Cough
Respiratory Tract Infections
Intervention  Drug: Dextromethorphan
Drug: Buckwheat Honey
MEDLINE PMIDs
Links Pediatric Clinical Research Office: Penn State Milton S. Hershey Medical Center This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Completed
Enrollment  105
Start Date  September 2005
Completion Date December 2006
Eligibility Criteria 

Inclusion Criteria:

  • Ages 2 to <18 years
  • Cough due to upper respiratory tract infection (URI), as determined by physical examination
  • Sleep difficulty on the preceding night attributed to frequent cough
  • Ability to swallow liquids
  • Willingness of the child's guardian to participate in a survey

Exclusion Criteria:

  • Signs/symptoms of more serious/treatable disease
  • Itchy, watery eyes
  • Frequent sneezing, tachypnea (respiratory rate >95th percentile) or labored breathing; symptoms for 8 or more days.
  • History of asthma in the past 2 years
  • Chronic lung disease, or seizure disorder
  • Allergic reaction to honey or DM
  • Selective serotonin reuptake inhibitors (SSRIs) or anti-malarial drugs
  • Diabetes mellitus or signs/symptoms of insulin resistance
Gender Both
Ages 2 Years to 18 Years
Accepts Healthy Volunteers No
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00127686
Organization ID 21163
Secondary IDs ††
Study Sponsor  Penn State University
Collaborators †† National Honey Board
Investigators 
Principal Investigator:     Ian M Paul, MD, MSc     Penn State College of Medicine    
Information Provided By Penn State University
Verification Date November 2007
First Received Date  August 4, 2005
Last Updated Date November 30, 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers